Leading global biologics R&D With one of the largest, most robust pipelines in the industry — including more than 120 research projects and product candidates — we comprise nearly half of AstraZeneca’s overall R&D portfolio. We are focused on three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease. But, we also are opportunity-driven in Infectious Disease.
The following is the list of scholars from MedImmune LLC who contributed and/or serves as editors for one or more OMICS International journals and conferences
The following is the list of articles by scholars from MedImmune LLC that are published in OMICS International journals.
The following is the list of proceedings by scholars from MedImmune LLC that are published in OMICS International journals and conferences.